Journey Medical Corp. (DERM) NASDAQ
$3.43 (0.12) (-3.25%)
Market Cap: $49.32M
As of 04/24/24 03:52 PM EDT. Market closed.
Journey Medical Corp. (DERM)
NASDAQ
$3.43
(0.12) (-3.25%)
Market Cap: $49.32M
As of 04/24/24 03:52 PM EDT. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO Compensation (Base)
$572,500
CEO Compensation (Total)
$4.37M
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO Compensation (Base)
$572,500
CEO Compensation (Total)
$4.37M
URL
Address
.
PRICE CHART FOR JOURNEY MEDICAL CORP
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.50
Previous Close
$3.54
Days Range
$3.46 - $3.59
52 week range
$1.02 - $8.11
Volume
60,469
Avg. Volume (30 days)
206,159
Market Cap
$49.32M
Dividend Yield
-
P/E
(12.80)
Shares Outstanding
13,932,310
Open
$3.50
Previous Close
$3.54
Days Range
$3.46 - $3.59
52 week range
$1.02 - $8.11
Volume
60,469
Avg. Volume (30 days)
206,159
Market Cap
$49.32M
Dividend Yield
-
P/E
(12.80)
Shares Outstanding
13,932,310
FINANCIAL STATEMENTS FOR JOURNEY MEDICAL CORP
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR JOURNEY MEDICAL CORP
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| ROSENWALD LINDSAY A MD | Director | Mar 25, 2024 | Buy | $3.04 | 10,000 | 30,400 | 144,245 | Mar 27, 2024, 07:00 AM |
| Maraoui Claude | President & CEO | Mar 22, 2024 | Buy | $3.48 | 10,000 | 34,790 | 2,163,430 | Mar 25, 2024, 04:03 PM |
| Smith Justin Adam | Director | Mar 22, 2024 | Buy | $3.47 | 30,000 | 104,100 | 134,717 | Mar 25, 2024, 04:02 PM |
| ROSENWALD LINDSAY A MD | Director | Mar 22, 2024 | Buy | $3.40 | 20,000 | 68,000 | 134,245 | Mar 25, 2024, 04:01 PM |
| Benesch Joseph | Interim CFO | Feb 22, 2024 | Sale | $3.75 | 2,450 | 9,188 | 60,710 | Feb 23, 2024, 05:54 PM |
| Paley Jeffrey | Director | Nov 08, 2023 | Sale | $3.76 | 255 | 959 | 114,217 | Dec 08, 2023, 05:01 PM |
| Paley Jeffrey | Director | Nov 07, 2023 | Sale | $3.48 | 2,245 | 7,813 | 114,472 | Dec 08, 2023, 05:01 PM |
| Paley Jeffrey | Director | Nov 28, 2023 | Sale | $5.22 | 1,745 | 9,109 | 70,727 | Nov 29, 2023, 04:42 PM |
| Smith Justin Adam | Director | Oct 13, 2023 | Buy | $2.98 | 33,000 | 98,340 | 104,717 | Oct 17, 2023, 04:01 PM |
| Paley Jeffrey | Director | Oct 06, 2023 | Buy | $2.98 | 15,000 | 44,700 | 72,472 | Oct 10, 2023, 04:41 PM |
| Paley Jeffrey | Director | Sep 21, 2023 | Buy | $2.97 | 30,000 | 89,100 | 57,472 | Sep 25, 2023, 04:01 PM |
| Maraoui Claude | President & CEO | Sep 06, 2023 | Buy | $2.52 | 26,044 | 65,631 | 2,153,430 | Sep 08, 2023, 01:26 PM |
| ROSENWALD LINDSAY A MD | Director | Sep 06, 2023 | Buy | $2.23 | 100,000 | 223,000 | 114,245 | Sep 08, 2023, 01:25 PM |
| Maraoui Claude | President & CEO | Jul 24, 2023 | Sale | $1.76 | 20,767 | 36,550 | 2,127,386 | Jul 25, 2023, 04:05 PM |
| Benesch Joseph | See Remarks | Jul 24, 2023 | Sale | $1.76 | 4,072 | 7,167 | 63,160 | Jul 25, 2023, 04:05 PM |
| Maraoui Claude | President & CEO | May 16, 2023 | Sale | $1.25 | 20,000 | 25,000 | 2,172,530 | May 18, 2023, 04:31 PM |
| Maraoui Claude | President & CEO | May 17, 2023 | Sale | $1.34 | 24,377 | 32,665 | 2,148,153 | May 18, 2023, 04:31 PM |
| De Paolantonio Ernest Robert | See Remarks | Oct 04, 2022 | Sale | $2.41 | 10,093 | 24,324 | 259,907 | Mar 01, 2023, 09:46 PM |
| Benesch Joseph | Interim CFO | Feb 22, 2023 | Sale | $1.97 | 2,768 | 5,453 | 67,232 | Feb 23, 2023, 05:01 PM |
| De Paolantonio Ernest Robert | Chief Financial Officer | Oct 04, 2022 | Sale | $2.41 | 10,093 | 24,324 | 259,907 | Oct 06, 2022, 04:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| ROSENWALD LINDSAY A MD | Director | 03/25/2024 | 30,400 |
| Maraoui Claude | President & CEO | 03/22/2024 | 34,790 |
| Smith Justin Adam | Director | 03/22/2024 | 104,100 |
| ROSENWALD LINDSAY A MD | Director | 03/22/2024 | 68,000 |
| Benesch Joseph | Interim CFO | 02/22/2024 | 9,188 |
| Paley Jeffrey | Director | 11/08/2023 | 959 |
| Paley Jeffrey | Director | 11/07/2023 | 7,813 |
| Paley Jeffrey | Director | 11/28/2023 | 9,109 |
| Smith Justin Adam | Director | 10/13/2023 | 98,340 |
| Paley Jeffrey | Director | 10/06/2023 | 44,700 |
| Paley Jeffrey | Director | 09/21/2023 | 89,100 |
| Maraoui Claude | President & CEO | 09/06/2023 | 65,631 |
| ROSENWALD LINDSAY A MD | Director | 09/06/2023 | 223,000 |
| Maraoui Claude | President & CEO | 07/24/2023 | 36,550 |
| Benesch Joseph | See Remarks | 07/24/2023 | 7,167 |
| Maraoui Claude | President & CEO | 05/16/2023 | 25,000 |
| Maraoui Claude | President & CEO | 05/17/2023 | 32,665 |
| De Paolantonio Ernest Robert | See Remarks | 10/04/2022 | 24,324 |
| Benesch Joseph | Interim CFO | 02/22/2023 | 5,453 |
| De Paolantonio Ernest Robert | Chief Financial Officer | 10/04/2022 | 24,324 |
Load More Insider Transactions
FUNDS WITH A POSITION IN JOURNEY MEDICAL CORP
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 261,000 | 0.00233% | 1148.8% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 85,785 | 0.00005% | 23.42% | Other |
| BLACKROCK INC. | 43,892 | 0.00001% | 204.97% | Other |
CHANGE IN SHARES OUTSTANDING FOR JOURNEY MEDICAL CORP
STOCK BUYBACKS FOR JOURNEY MEDICAL CORP
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-11.13%
1Q
06/30/2023
3.83%
2Q
03/31/2023
4.98%
3Q
12/31/2022
5.43%
4Q
09/30/2022
6.11%
5Q
06/30/2022
7.09%
6Q
03/31/2022
7.95%
7Q
12/31/2021
83.46%
8Q
03/31/2021
71.55%
11Q
12/31/2020
71.64%
12Q
09/30/2020
73.09%
13Q
06/30/2020
72.57%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR JOURNEY MEDICAL CORP
LOADING...